Follow, research and publish the best content
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
New pharma
13.8K views |
+0 today
 Your new post is loading...
Scoop.it!
Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn't shared evenly between the biggest of pharmas, as a number of players scaled up.
Roche cut deepest among big pharmas, lopping off a third of its Full-Time Rep Equivalents, while Abbott and Sanofi were close behind, downsizing 23% of their FTEs, according to an analysis by Cegedim Strategic Data. GSK cut its FTE force by 22% and Bayer by 19%.
But Boehringer Ingelheim and Novo Nordisk went on hiring sprees, bumping up their FTE numbers by 15% and 13%, respectively, while AstraZeneca and Warner Chilcott increased FTEs 11%. Amgen's FTE count was up a whopping 32%. A number of smaller and mid-sized pharmas were hiring, too, including Gilead, Endo, Elorac and Somaxon.
Driving hiring at AstraZeneca was promotion of Crestor, the nation's most-detailed brand in 2011 with around 2.5 million details. The next-most-detailed brands were Cymbalta and Bystolic, with 2.1 million details, followed by Celebrex and Seretide, with 1.9 million, Lipitor with 1.7 million, Spiriva with 1.6 million and Symbicort and Pradaxa with 1.5 million.
The average length of details declined again in 2011, to under 5 minutes. In 2007, 70% of details were over 5 minutes. Increasingly, said Cegedim, physicians' offices, under pressure from managed care and having increased patient volume to make up for less reimbursement, “are setting aside only a small, highly competitive window of time per week for details,” while others stop seeing reps altogether. Complicating access for reps is the fact that their employers, seeking cost-savings, are pulling back on samples, which dropped again in 2011, while brochure leave-behinds increased. Reps armed with samples are more likely to get a foot in the door than those carrying only brochures, but samples are costly to companies. Via Thibaud Guymard 
Scoop.it!
The current pharma landscape still doesn't offer guidelines for social media participation, but it's not stopping patients from talking and influencing their networks. Going culture casting and enlisting the help of the most ...
Scoop.it!
In a heavily regulated industry like pharma, where other companies are hesitant to engage in social media because of the potential risks, Sanofi US is demonstrating that social media engagement can be highly successful, ...
Scoop.it!
To survive, the biotech guru says, Big Pharma must ignore the “gravel in the road” and continue driving towards personalized medicine.
ScientificAnimations's comment,
May 8, 2018 9:40 AM
Tumors have genetic changes that cause cancer to grow and spread; and consequently, the changes that occur in one person’s cancer may not occur in others who have the same type of cancer. Also, the same mutations can trigger different types of cancer in different people. That's why we need a personalised approach to treat them. Check out what's happening in this field: http://sco.lt/73Bwy9
Scoop.it!
Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by GBI Research
Scoop.it!
|
|
Scooped by
rob halkes
May 3, 2012 12:57 PM
|
Scoop.it!
A new manhattanResearch report suggests that physicians who touched a sales rep's iPad were more likely to have a satisfactory experience, and more likely to say the experience influenced their clinical decisions.
However, only one-quarter of the 30 percent of physicians who saw a sales rep with an iPad actually touched the device during the meeting.
[AS: a new chapter in the mythologising of the arcane, totemic qualities of the iPad as an influencer of physician behaviour is written with the release of this data.
What exactly is it about the way that content is presented by iOS which leads doctors to feel as though they have been more influenced than they would have done were it presented on either another tablet, or perhaps a laptop?
Is it the tactile nature of the experience? The ability of iOS to render graphics? Or a conditioned response on the part of the audience that associates the tablet with other experiences?
It is also interesting to note that reps seem unwilling to let the tablet out of their hands, and let the doctor 'drive' the detail. I would have thought '1. pass the iPad to the clinician' was the first item on the Successful Digital Detailing 101 training program.]
|
|
Scooped by
rob halkes
May 2, 2012 7:46 AM
|
Scoop.it!
The GuardianStudy reveals scale of errors on doctors' prescriptionsThe GuardianA study commissioned by the GMC, which regulates doctors, found that over the course of a year, one in 20 prescription items had some sort of error or monitoring of the...
|
|
Scooped by
rob halkes
May 2, 2012 7:33 AM
|
Scoop.it!
TweetPharm is a free interactive infographic that tracks pharmaceutical companies' use of Twitter.
|
|
Scooped by
rob halkes
May 2, 2012 5:47 AM
|
Scoop.it!
When big pharma looks in the mirror, what does it see A body beset by old, expiring brands and not enough energetic, youthful ones to replace them.
|
|
Rescooped by
rob halkes
from HEALTHCARE & SOCIAL MEDIA
May 2, 2012 12:47 AM
|
Scoop.it!
Strategy for pharmaceutical marketing and communications professionals- presentations and video content from our events covering, digital, mobile and social ...
Via Thierry Le Magny, Lionel Reichardt / le Pharmageek
Auvaro Philippe's comment,
May 2, 2012 12:44 AM
Merci beaucoup; c'est dommage que Jens soit oblige d'accelerer vers la fin. Peut-on avoir acces a ses slides sur un post de la conference?
|
|
Scooped by
rob halkes
May 2, 2012 12:38 AM
|
Scoop.it!
Two years ago, we created a Social Media 101 class – basically, a bootcamp for pharma marketers who wanted to understand how social media was changing how (RT @iQLab: Social Media for Health: A 201 level look at state of social media in healthcare...
|
|
Scooped by
rob halkes
May 2, 2012 12:26 AM
|
Scoop.it!
A recent survey of 140 Lupin Pharmaceuticals, Inc., field sales reps and district managers assessing the impact of BusinessOne Technologies, Inc.&rsqu...
|
|
Scooped by
rob halkes
May 1, 2012 4:01 AM
|
Scoop.it!
When no news is bad newsMedical Marketing and MediaBut guess what? Very few people outside of pharma are even aware of these issues. Even if they were, chances are they wouldn't care. So perhaps it's time to stop assuming that they do.
|
|
Scooped by
rob halkes
April 28, 2012 3:20 AM
|
Scoop.it!
Survey: Pharma lags peers in gaining trust via social media
Read more: Survey: Pharma lags peers in gaining trust via social media - FierceBiotechIT http://www.fiercebiotechit.com/story/survey-pharma-lags-peers-gaining-trust-social-media/2012-04-23#ixzz1ssxf5LNn
Subscribe: http://www.fiercebiotechit.com/signup?sourceform=Viral-Tynt-FierceBiotechIT-FierceBiotechIT
|
|
Scooped by
rob halkes
April 23, 2012 1:26 PM
|
Scoop.it!
Survey: Pharma lags peers in gaining trust via social media
Read more: Survey: Pharma lags peers in gaining trust via social media - FierceBiotechIT http://www.fiercebiotechit.com/story/survey-pharma-lags-peers-gaining-trust-social-media/2012-04-23#ixzz1ssxf5LNn
Subscribe: http://www.fiercebiotechit.com/signup?sourceform=Viral-Tynt-FierceBiotechIT-FierceBiotechIT
|
|
Scooped by
rob halkes
April 23, 2012 1:24 PM
|
Scoop.it!
All the top 10 pharma companies use social media, here's how - PMLiVE...
|
|
Scooped by
rob halkes
April 23, 2012 12:34 AM
|
Scoop.it!
Programme - Day One Wednesday 25th April - Addressing how to mobilise healthcare content to engage and provide information to your stakeholders.
|
|
Scooped by
rob halkes
April 18, 2012 2:51 AM
|
Scoop.it!
This is an article about how pharma can better interact with patient communities.
|
|
Scooped by
rob halkes
April 11, 2012 3:24 PM
|
Scoop.it!
excerpt: We are launching a great new pharma marketing event this year that will run alongside DigiPharm, the Pharma Marketing Show. I’ve been working on putting the agenda and speaker panel together over the last couple of months..
|
|
Scooped by
rob halkes
April 11, 2012 1:13 AM
|
Scoop.it!
The massmarket, TVandprint DTC formula is going the way of the vanishing primary care blockbusters it was designed to boost as new media and niche products fill the breach, Matthew Arnold reports...
|
|
Scooped by
rob halkes
April 10, 2012 5:26 AM
|
Scoop.it!
what will it take for hospitals to be the best run organizations on the face of the planet?
